Obesity, Innovation, Action: The WHO Roadmap for GLP-1 Therapies 🌐🚀📘

🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘   The latest JAMA report highlights a pivotal moment in global health: the WHO's evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care.   The guidance underscores two essentials: 💊 Long-term GLP-1 therapy for those living with obesity 🤝 Intensive behavioral support to amplify and sustain benefits   But the message is clear—medication alone is not enough. True progress requires strong health systems, equitable access, and person-centered prevention and care.   A timely call to action for clinicians, policymakers, and health leaders everywhere. 🌱🌐